EIR's system targets fundamental structures rather than specific products. A solution built for one application transfers to any product facing a similar problem, with minimal additional intervention. Each application compounds our existing science.
Impurities and PAHs are a persistent compliance hurdle for exports to the EU, US, and Japan. EIR reduces them at the foundational level — no chemical washing, no heat, no residue.
Hygroscopic bonds in moisture-sensitive APIs and excipients drive yield loss, batch rejection, and cold-chain cost. EIR disrupts them non-thermally — preserving structure where lyophilization and fluid-bed drying degrade it.
EIR selectively raises the concentration of target bioactives in a raw material — no solvent extraction, no heat, no change to the surrounding matrix. Higher potency from existing supply chains.